News Digest / Ticker: CRBP

Ticker: CRBP

08:21am, Thursday, Dec 11, 2025

Corbus Pharmaceuticals Shares Gain on Encouraging Obesity Drug Safety Results

Corbus Pharmaceuticals (NASDAQ:CRBP) stock climbed 5% following positive Phase 1a trial results for CRB-913, showing a solid safety profile and early signs of weight loss in obesity treatment.